1410 related articles for article (PubMed ID: 11899413)
21. A review of vinorelbine in the treatment of breast cancer.
Domenech GH; Vogel CL
Clin Breast Cancer; 2001 Jul; 2(2):113-28. PubMed ID: 11899783
[TBL] [Abstract][Full Text] [Related]
22. Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer.
Raez LE; Kobina S; Santos ES
Clin Lung Cancer; 2010 Jan; 11(1):18-24. PubMed ID: 20085863
[TBL] [Abstract][Full Text] [Related]
23. A phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer.
Yardley DA; Daniel D; Stipanov M; Drosick DR; Mainwaring M; Peyton J; Shastry M; Hainsworth JD
Cancer Invest; 2010 Oct; 28(8):865-71. PubMed ID: 20690802
[TBL] [Abstract][Full Text] [Related]
24. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Heinemann V
Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
[TBL] [Abstract][Full Text] [Related]
25. Trastuzumab/chemotherapy combinations in metastatic breast cancer.
Ligibel JA; Winer EP
Semin Oncol; 2002 Jun; 29(3 Suppl 11):38-43. PubMed ID: 12138396
[TBL] [Abstract][Full Text] [Related]
26. Combination versus sequential single-agent therapy in metastatic breast cancer.
Miles D; von Minckwitz G; Seidman AD
Oncologist; 2002; 7 Suppl 6():13-9. PubMed ID: 12454315
[TBL] [Abstract][Full Text] [Related]
27. Preoperative therapy with trastuzumab and oral vinorelbine (+/- endocrine therapy) in patients with HER2-positive breast cancer.
Iorfida M; Bagnardi V; Balduzzi A; Dellapasqua S; Cardillo A; Luini A; Intra M; Minchella I; Veronesi P; Viale G; Goldhirsch A; Colleoni M
Breast; 2010 Apr; 19(2):128-32. PubMed ID: 20117001
[TBL] [Abstract][Full Text] [Related]
28. Trastuzumab emtansine, an antibody-drug conjugate for the treatment of HER2+ metastatic breast cancer.
Niculescu-Duvaz I
Curr Opin Mol Ther; 2010 Jun; 12(3):350-60. PubMed ID: 20521224
[TBL] [Abstract][Full Text] [Related]
29. The current status of docetaxel for metastatic breast cancer.
Esteva FJ
Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):17-26. PubMed ID: 12108894
[TBL] [Abstract][Full Text] [Related]
30. A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study.
Alba E; Chacon JI; Lluch A; Anton A; Estevez L; Cirauqui B; Carrasco E; Calvo L; Segui MA; Ribelles N; Alvarez R; Sanchez-Muñoz A; Sanchez R; Garcia-Asenjo JA; Rodriguez-Martin C; Escudero MJ; Albanell J
Breast Cancer Res Treat; 2012 Nov; 136(2):487-93. PubMed ID: 23053638
[TBL] [Abstract][Full Text] [Related]
31. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
[TBL] [Abstract][Full Text] [Related]
32. The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer.
Vermorken JB
Int J Gynecol Cancer; 2001; 11 Suppl 1():21-30. PubMed ID: 11488999
[TBL] [Abstract][Full Text] [Related]
33. Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.
Teicher BA; Chen V; Shih C; Menon K; Forler PA; Phares VG; Amsrud T
Clin Cancer Res; 2000 Mar; 6(3):1016-23. PubMed ID: 10741729
[TBL] [Abstract][Full Text] [Related]
34. The evolving role of capecitabine in breast cancer.
O'Shaughnessy JA
Clin Breast Cancer; 2003 Apr; 4 Suppl 1():S20-5. PubMed ID: 12756075
[TBL] [Abstract][Full Text] [Related]
35. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
O'Shaughnessy J
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
[TBL] [Abstract][Full Text] [Related]
36. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer.
Pegram MD; Konecny GE; O'Callaghan C; Beryt M; Pietras R; Slamon DJ
J Natl Cancer Inst; 2004 May; 96(10):739-49. PubMed ID: 15150302
[TBL] [Abstract][Full Text] [Related]
37. Gemcitabine in combination with trastuzumab and/or platinum salts in breast cancer cells with HER2 overexpression.
Konecny GE; Pegram MD
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):32-6. PubMed ID: 15685824
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
Lissoni P; Brivio F; Fumagalli L; Messina G; Ghezzi V; Frontini L; Giani L; Vaghi M; Ardizzoia A; Gardani GS
Int J Biol Markers; 2004; 19(2):135-40. PubMed ID: 15255546
[TBL] [Abstract][Full Text] [Related]
39. [Role of adjuvant chemotherapy in the choice of chemotherapeutic treatment of metastatic breast cancer].
Lopez M; Di Lauro L; Viola G; Conti F; Foggi P; Vici P
Clin Ter; 2009; 160(6):489-97. PubMed ID: 20198293
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety.
Pentheroudakis G; Razis E; Athanassiadis A; Pavlidis N; Fountzilas G
Med Oncol; 2006; 23(2):147-60. PubMed ID: 16720915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
